4-(1H-isoindol-4-yl)-6-methyl-7-[(4-methylsulfonylpiperazin-1-yl)methyl]-2-piperazin-1-ylthieno[3,2-d]pyrimidine
C25H31N7O2S2 — CID 157368503
Data last refreshed: (MolForge compound catalog, from PubChem)
About 4-(1H-isoindol-4-yl)-6-methyl-7-[(4-methylsulfonylpiperazin-1-yl)methyl]-2-piperazin-1-ylthieno[3,2-d]pyrimidine
4-(1H-isoindol-4-yl)-6-methyl-7-[(4-methylsulfonylpiperazin-1-yl)methyl]-2-piperazin-1-ylthieno[3,2-d]pyrimidine (PubChem CID 157368503) has the molecular formula C25H31N7O2S2 and a molecular weight of 525.70 g/mol. Its IUPAC name is 4-(1H-isoindol-4-yl)-6-methyl-7-[(4-methylsulfonylpiperazin-1-yl)methyl]-2-piperazin-1-ylthieno[3,2-d]pyrimidine.
Molecular Properties
| Compound Name | 4-(1H-isoindol-4-yl)-6-methyl-7-[(4-methylsulfonylpiperazin-1-yl)methyl]-2-piperazin-1-ylthieno[3,2-d]pyrimidine |
|---|---|
| PubChem CID | 157368503 |
| Molecular Formula | C25H31N7O2S2 |
| Molecular Weight | 525.70 g/mol |
| Exact Mass | 525.20 |
| IUPAC Name | 4-(1H-isoindol-4-yl)-6-methyl-7-[(4-methylsulfonylpiperazin-1-yl)methyl]-2-piperazin-1-ylthieno[3,2-d]pyrimidine |
| SMILES | Cc1sc2c(-c3cccc4c3C=NC4)nc(N3CCNCC3)nc2c1CN1CCN(S(C)(=O)=O)CC1 |
| InChI | InChI=1S/C25H31N7O2S2/c1-17-21(16-30-10-12-32(13-11-30)36(2,33)34)23-24(35-17)22(19-5-3-4-18-14-27-15-20(18)19)28-25(29-23)31-8-6-26-7-9-31/h3-5,15,26H,6-14,16H2,1-2H3 |
| InChIKey | UVEDWQQONACGFF-UHFFFAOYSA-N |
| XLogP | 2.09 |
| TPSA | 94.03 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 9 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 36 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 525.70 |
| LogP ≤ 5 | 2.09 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 9 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 157368503 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.